A pill instead of a shot — orforglipron could change who has access to GLP-1 weight-loss treatment. Here's everything you need to know: how it compares to Mounjaro and Wegovy, what the trials show, and what comes next with CagriSema and triple-receptor drugs.
Practical tips on health, routines, productivity, and finance — to help you build a stronger daily life. We simplify complex information into clear, actionable guidance you can apply starting today.